LO LOESTRIN FE: payments to doctors
Payments that named LO LOESTRIN FE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.8M
- Providers
- 26,493
- Transactions
- 169,860
- Average per transaction
- $17
The per-transaction average — $17 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 26,493 providers the average total is $107, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| AbbVie | $2,836,214 | 100.0% |